Legacy EJY (ENJYQ) S-4/A 23 Aug 21 Registration of securities issued in business combination transactions (amended) Financial data

Cover Page

Cover Page	6 Months Ended
	Jun. 30, 2021
Document Information [Line Items]
Document Type	S-4/A
Amendment Flag	false
Entity Registrant Name	Marquee Raine Acquisition Corp.
Entity Central Index Key	0001830180
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash	$ 877,620	$ 2,266,049
Prepaid expenses	636,568	831,645
Total current assets	1,514,188	3,097,694
Cash held in Trust Account	373,750,000	373,750,000
Total Assets	375,264,188	376,847,694
Current liabilities:
Accounts payable	4,289,351	578,902
Accrued expenses	1,014,468	488,824
Total current liabilities	5,303,819	1,067,726
Deferred legal fees	462,409	0
Deferred underwriting commissions	13,081,250	13,081,250
Derivative warrant liabilities	20,045,330	27,249,130
Total liabilities	38,892,808	41,398,106
Commitments and Contingencies
Class A ordinary shares, $0.0001 par value; 33,137,137 and 33,044,958 shares subject to possible redemption at $10.00 per share at June 30, 2021 and December 31, 2020, respectively	331,371,370	330,449,580
Shareholders' Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at June 30, 2021 and December 31, 2020	0	0
Additional paid-in capital	8,446,652	9,830,842
Accumulated deficit	(3,448,000)	(4,832,201)
Total shareholders' equity	5,000,010	5,000,008
Total Liabilities and Shareholders' Equity	375,264,188	376,847,694
Common Class A [Member]
Shareholders' Equity
Common Stock	424	433
Common Class B [Member]
Shareholders' Equity
Common Stock	$ 934	$ 934

Condensed Balance Sheets (Paren

Condensed Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2021	Dec. 31, 2020
Preference shares par value	$ 0.0001	$ 0.0001
Preference shares authorized	5,000,000	5,000,000
Preference shares issued	0	0
Preference shares outstanding	0	0
Common Class A [Member]
Class A ordinary shares par value	$ 0.0001	$ 0.0001
Ordinary shares subject to possible redemption	33,137,137	33,044,958
Ordinary shares redemption price per share	$ 10	$ 10
Ordinary shares par value	$ 0.0001	$ 0.0001
Ordinary shares authorized	500,000,000	500,000,000
Ordinary shares issued	4,237,863	4,330,042
Ordinary shares outstanding	4,237,863	4,330,042
Common Class B [Member]
Ordinary shares par value	$ 0.0001	$ 0.0001
Ordinary shares authorized	50,000,000	50,000,000
Ordinary shares issued	9,343,750	9,343,750
Ordinary shares outstanding	9,343,750	9,343,750

Condensed Statements of Operati

Condensed Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2021
General and administrative expenses	$ 2,357,741	$ 127,691	$ 5,819,599
Loss from operations	(2,357,741)	(127,691)	(5,819,599)
Other income / (expense)
Change in fair value of derivative warrant liabilities	(626,410)	(3,758,500)	7,203,800
Transaction costs—derivative warrant liabilities		(946,010)
Net income (loss)	$ (2,984,151)	$ (4,832,201)	$ 1,384,201
Common Class A [Member]
Other income / (expense)
Weighted average ordinary shares outstanding, basic and diluted	37,375,000	37,375,000	37,375,000
Basic and diluted net income (loss) per ordinary share	$ 0	$ 0	$ 0
Common Class B [Member]
Other income / (expense)
Weighted average ordinary shares outstanding, basic and diluted	9,343,750	8,429,688	9,343,750
Basic and diluted net income (loss) per ordinary share	$ (0.32)	$ (0.57)	$ 0.15

Condensed Statements Of Changes

Condensed Statements Of Changes In Shareholders' Equity - USD ($)	Total	Additional Paid-in Capital	Accumulated Deficit	Class A [Member]Ordinary Shares	Class B [Member]Ordinary Shares
Beginning balance at Oct. 15, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Oct. 15, 2020				0	0
Issuance of Class B ordinary shares to Sponsor	25,000	24,066			$ 934
Issuance of Class B ordinary shares to Sponsor (in shares)					9,343,750
Sale of units in initial public offering, less fair value of public warrants	359,734,370	359,730,632		$ 3,738
Sale of units in initial public offering, less fair value of public warrants (in shares)				37,375,000
Offering costs	(19,477,581)	(19,477,581)
Shares subject to possible redemption	(330,449,580)	(330,446,275)		$ (3,305)
Shares subject to possible redemption (in shares)				(33,044,958)
Net income	(4,832,201)		(4,832,201)
Ending balance at Dec. 31, 2020	5,000,008	9,830,842	(4,832,201)	$ 433	$ 934
Ending balance (in shares) at Dec. 31, 2020				4,330,042	9,343,750
Offering costs	(266,102)	(266,102)
Shares subject to possible redemption	(4,102,250)	(4,102,209)		$ (41)
Shares subject to possible redemption (in shares)				(410,225)
Net income	4,368,352		4,368,352
Ending balance at Mar. 31, 2021	5,000,008	5,462,531	(463,849)	$ 392	$ 934
Ending balance (in shares) at Mar. 31, 2021				3,919,817	9,343,750
Beginning balance at Dec. 31, 2020	5,000,008	9,830,842	(4,832,201)	$ 433	$ 934
Beginning balance (in shares) at Dec. 31, 2020				4,330,042	9,343,750
Net income	1,384,201
Ending balance at Jun. 30, 2021	5,000,010	8,446,652	(3,448,000)	$ 424	$ 934
Ending balance (in shares) at Jun. 30, 2021				4,237,863	9,343,750
Beginning balance at Mar. 31, 2021	5,000,008	5,462,531	(463,849)	$ 392	$ 934
Beginning balance (in shares) at Mar. 31, 2021				3,919,817	9,343,750
Offering costs	(196,307)	(196,307)
Shares subject to possible redemption	3,180,460	3,180,428		$ 32
Shares subject to possible redemption (in shares)				318,046
Net income	(2,984,151)		(2,984,151)
Ending balance at Jun. 30, 2021	$ 5,000,010	$ 8,446,652	$ (3,448,000)	$ 424	$ 934
Ending balance (in shares) at Jun. 30, 2021				4,237,863	9,343,750

Condensed Statement of Cash Flo

Condensed Statement of Cash Flows - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Cash Flows from Operating Activities:
Net income	$ (4,832,201)	$ 1,384,201
Adjustment to reconcile net income to net cash used in operating activities:
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares	25,000
Change in fair value of derivative warrant liabilities	3,758,500	(7,203,800)
Transaction costs—derivative warrant liabilities	946,010
Changes in operating assets and liabilities:
Prepaid expenses	(831,645)	195,077
Accounts payable	578,902	3,710,449
Accrued expenses	53,590	890,878
Net cash used in operating activities	(301,844)	(1,023,195)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(373,750,000)
Net cash used in investing activities	(373,750,000)
Cash Flows from Financing Activities:
Proceeds received from note payable to related party	127,850
Repayment of note payable to related party	(127,850)
Proceeds received from initial public offering, gross	373,750,000
Proceeds received from private placement	9,475,000
Reimbursement from underwriters	2,990,000
Offering costs paid	(9,897,107)	(365,234)
Net cash used in financing activities	376,317,893	(365,234)
Net change in cash	2,266,049	(1,388,429)
Cash - beginning of the period	0	2,266,049
Cash - end of the period	2,266,049	877,620
Supplemental disclosure of noncash financing activities:
Deferred legal fees		462,409
Offering costs included in accrued expenses	435,234
Deferred underwriting commissions	13,081,250
Initial value of Class A ordinary shares subject to possible redemption	333,685,710
Change in initial value of Class A ordinary shares subject to possible redemption	(3,236,130)	$ 921,790
Initial measurement of derivative warrants issued in connection with the initial public offering accounted for as liabilities	$ 23,490,630

Description of Organization and

Description of Organization and Business Operations	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Marquee Raine Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on October 16, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from October 16, 2020 (inception) through December 31, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. In the future, the Company may generate non-operating income in the The Company’s sponsor is Marquee Raine Acquisition Sponsor LP (the “Sponsor”), a Cayman Islands exempted limited partnership and an affiliate of The Raine Group LLC (together with its affiliates, “The Raine Group”) and Marquee Sports Holdings SPAC I, LLC (“Marquee”). The registration statement for the Company’s Initial Public Offering was declared effective on December 14, 2020. On December 17, 2020, the Company consummated its Initial Public Offering of 37,375,000 Units, including 4,875,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $373.8 million, and incurring offering costs of approximately $19.5 million, of which approximately $13.1 million was deferred underwriting commissions (Note 6). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,316,667 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $9.5 million (Note 5). Upon the closing of the Initial Public Offering and the Private Placement, approximately $373.8 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a non-interest bearing trust under Rule 2a-7 promulgated under The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions) at the time of the signing of the agreement to enter into the Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act). The Company will provide the holders of the public shares with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share amount of any material non-public information and (ii) to Notwithstanding the foregoing, our amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A Ordinary Shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the amended and restated memorandum and articles of association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or December 17, 2022, (the “Combination Period”) or (b) with respect to any other provision relating to shareholders’ rights or pre-Business If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in The Sponsor agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or members of the Company’s management team acquire public shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive its rights to its deferred underwriting commissions (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity As of December 31, 2020, the Company had cash of approximately $2.3 million outside of the Trust Account and working capital of approximately $2.0 million. The Company will use these funds for paying existing accounts payable, identifying and evaluating prospective Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.	Note 1 — Description of Organization and Business Operations Marquee Raine Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on October 16, 2020. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of June 30, 2021, the Company had not commenced any operations. All activity for the period from October 16, 2020 (inception) through June 30, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its Business Combination, at the earliest. In the future, the Company may generate non-operating The Company’s sponsor is Marquee Raine Acquisition Sponsor LP (the “Sponsor”), a Cayman Islands exempted limited partnership and an affiliate of The Raine Group LLC (together with its affiliates, “The Raine Group”) and Marquee Sports Holdings SPAC I, LLC (“Marquee”). The registration statement for the Company’s Initial Public Offering was declared effective on December 14, 2020. On December 17, 2020, the Company consummated its Initial Public Offering of 37,375,000 Units, including 4,875,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $373.8 million, and incurring offering costs of approximately $19.9 million, of which approximately $13.1 million was deferred underwriting commissions and $0.5 million was deferred legal fees (Note 3). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,316,667 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $9.5 million (Note 4). Upon the closing of the Initial Public Offering and the Private Placement, approximately $373.8 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a non-interest 2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding any deferred underwriting commissions and deferred legal fees) at the time of the signing of the agreement to enter into the Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act). The Company will provide the holders of the public shares with the opportunity to redeem all or a portion of their public shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public shareholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share). The per-share non-public Notwithstanding the foregoing, our amended and restated memorandum and articles of association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A Ordinary Shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the amended and restated memorandum and articles of association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its public shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or December 17, 2022, (the “Combination Period”) or (b) with respect to any other provision relating to shareholders’ rights or pre- If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share The Sponsor agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or members of the Company’s management team acquire public shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such public shares if the Company fails to complete a Business Combination within the Combination Period. The underwriter agreed to waive its rights to its deferred underwriting commissions and deferred legal fees (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the public shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriter of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Proposed Business Combination On April 28, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with MRAC Merger Sub Corp., a wholly owned subsidiary of the Company (“Merger Sub”) and Enjoy Technology Inc. (“Enjoy”). The Merger Agreement provides that, among other things, the following transactions will occur (together with the other transactions contemplated by the Merger Agreement, including the Domestication (as defined below), (the “Proposed Business Combination”): (i) at the closing of the Proposed Business Combination (the “Closing”), Merger Sub will merge with and into Enjoy, the separate corporate existence of Merger Sub will cease and Enjoy will be the surviving corporation and a wholly owned subsidiary of the Company (the “Merger”); (ii) as a result of the Merger, among other things, each outstanding share of common stock of Enjoy (other than shares subject to Enjoy equity awards, treasury shares and dissenting shares) will be cancelled in exchange for the right to receive a number of shares of New Enjoy Common Stock (as defined below) equal to (x) the sum of (i) the Base Purchase Price (as defined below), plus (ii) the aggregate exercise price of each outstanding option to purchase common stock of Enjoy, plus (iii) the aggregate exercise price of each outstanding warrant of Enjoy, divided by (y) the aggregate number of shares of Enjoy common stock that are outstanding on a fully diluted basis as of immediately prior to closing, determined in accordance with the terms of the Merger Agreement, divided by (z) $10.00. The “Base Purchase Price” means the sum of (a) $1,028,738,000, plus (b) 125% of the aggregate amount actually funded prior to the Closing in connection with an Excluded Financing (as defined below), up to a maximum aggregate amount equal to $60 million, plus (c) the aggregate amount actually funded prior to the Closing in connection with an Excluded Financing (to the extent in excess of the amounts set forth in clause (b) above), up to a maximum aggregate amount equal to $15 million. The Board of Directors of the Company (the “Board”) unanimously (i) approved and declared advisable the Merger Agreement and the Business Combination and (ii) resolved to recommend approval of the Merger Agreement and related matters by the shareholders of the Company. The Merger Agreement may be terminated at any time prior to the Closing (i) by mutual written consent of the Company and Enjoy, (ii) by the Company or Enjoy, if certain approvals of the Company’s shareholders, to the extent required under the Merger Agreement, are not obtained as set forth therein, (iii) by Enjoy if there is a Modification in Recommendation (as defined in the Merger Agreement), (iv) by the Company if certain approvals of the shareholders of Enjoy are not obtained within twenty-four hours after the execution and delivery of the Merger Agreement and (v) by either the Company or Enjoy in certain other circumstances set forth in the Merger Agreement, including (a) if any Governmental Authority (as defined in the Merger Agreement) shall have issued or otherwise entered a final, nonappealable order making consummation of the Merger illegal or otherwise preventing or prohibiting consummation of the Merger, (b) in the event of certain uncured breaches by the other party or (c) if the Closing has not occurred on or before October 28, 2021. The Domestication Prior to the Closing, the Company will effect a deregistration under Cayman Islands Companies Law and a domestication under Delaware General Corporation Law, pursuant to which the Company’s jurisdiction of incorporation will be changed from the Cayman Islands to the State of Delaware (the “Domestication”). In connection with the Domestication, the Company, as the continuing entity in the Domestication, will be renamed “Enjoy Technology, Inc.” As used herein, “New Enjoy” refers to the Company after the Domestication, including after such change of name. In connection with the Domestication, (i) each of the Company’s then issued and outstanding Class A ordinary shares, par value $0.0001 per share (the “MRAC Class A Ordinary Shares”), will convert automatically, on a one-for-one one-for-one one-fourth Subscription Agreements On April 28, 2021, concurrently with the execution of the Merger Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with certain investors (collectively, the “PIPE Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE Investors have collectively subscribed for 8 million shares of the New Enjoy Common Stock for an aggregate purchase price equal to $80 million (the “PIPE Investment”). The PIPE Investment will be consummated substantially concurrently with the Closing. The Subscription Agreements will terminate with no further force and effect upon the earliest to occur of: (a) such date and time as the Merger Agreement is terminated in accordance with its terms; (b) the mutual written agreement of the parties to such Subscription Agreement or (c) October 28, 2021. Sponsor Agreement On April 28, 2021, concurrently with the execution of the Merger Agreement, the Company entered into a letter agreement (the “Sponsor Agreement”) with the Sponsor pursuant to which, among other things, in connection with the Closing, the Sponsor agreed to (i) waive certain anti-dilution rights set forth in the Company’s amended and restated memorandum and articles of association that may result from the Business Combination and (ii) subject 1,121,250 shares of New Enjoy Common Stock to potential forfeiture in the event that the volume-weighted average closing price of New Enjoy Common Stock does not equal or exceed $15.00 on 20 out of any 30 consecutive trading days after consummation of the Business Combination and prior to and including the fifth (5th) anniversary of the Closing. Going Concern As of June 30, 2021, the Company had approximately $878,000 in its operating bank account, and working deficit of approximately $3.8 million. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $128,000 from the Sponsor pursuant to the Note (see Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full upon closing of the Initial Public Offering. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of June 30, 2021, there were no amounts outstanding under any Working Capital Loan. The Company has incurred and expects to continue to incur significant costs in pursuit of the proposed Business Combination. The Company cannot provide any assurance that financing will be available to it on commercially acceptable terms, if at all. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for the one year period from date that the financial statements are issued. There is no assurance that the Company’s plans to consummate the proposed Business Combination will be successful or otherwise whether a business combination will be successful during the Combination Period. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	3 Months Ended
	Dec. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Restatement of Previously Issued Financial Statements	Note 2—RESTATEMENT OF PREVIOUSLY ISSUED FINANCAL STATEMENTS On April 12, 2021, the staff of the SEC issued a Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”) (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since issuance on December 17, 2020, the Company’s warrants were accounted for as equity within the Company’s previously reported balance sheets. After discussion and evaluation, including with the Company’s independent registered public accounting firm and the audit committee, management concluded that the warrants should be presented as liabilities with subsequent fair value re-measurement. Impact of the Restatement The impact of the restatement on the balance sheets, statement of operations and statement of cash flows for the Affected Period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. As of December 31, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 376,847,694 $ — $ 376,847,694 Liabilities and shareholders’ equity Total current liabilities $ 1,067,726 $ — $ 1,067,726 Deferred legal fees — — Deferred underwriting commissions 13,081,250 — 13,081,250 Derivative warrant liabilities — 27,249,130 27,249,130 Total liabilities 14,148,976 27,249,130 41,398,106 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 357,698,710 (27,249,130 ) 330,449,580 Shareholders’ equity Preference shares—$0.0001 par value — — — Class A ordinary shares—$0.0001 par value 161 272 433 Class B ordinary shares—$0.0001 par value 934 — 934 Additional paid-in-capital 5,126,604 4,704,238 9,830,842 Accumulated deficit (127,691 ) (4,704,510 ) (4,832,201 ) Total shareholders’ equity 5,000,008 — 5,000,008 Total liabilities and shareholders’ equity $ 376,847,694 $ — $ 376,847,694 Period From October 16, 2020 (Inception) As Previously Restatement As Restated Statement of Operations Loss from operations $ (127,691 ) $ — $ (127,691 ) Other (expense) income: Change in fair value of derivative warrant liabilities — (3,758,500 ) (3,758,500 ) Transaction costs—derivative warrant liabilities — (946,010 ) (946,010 ) Net gain from investments held in Trust Account — — — Total other (expense) income — (4,704,510 ) (4,704,510 ) Net loss $ (127,691 ) $ (4,704,510 ) $ (4,832,201 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 37,375,000 — 37,375,000 Basic and Diluted net loss per Class A share $ — — $ — Basic and Diluted weighted-average Class B ordinary shares outstanding 8,429,688 — 8,429,688 Basic and Diluted net loss per Class B share $ (0.02 ) $ (0.55 ) $ (0.57 ) Period From October 16, 2020 (Inception) Through As Previously Restatement As Restated Statement of Cash Flows Net loss $ (127,691 ) $ (4,704,510 ) $ (4,832,201 ) Change in fair value of derivative warrant liabilities — 3,758,500 3,758,500 Transaction costs - derivative warrant liabilities — 946,010 946,010 In addition, the impact to the balance sheet dated December 17, 2020, filed on Form 8-K

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for financial information and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for the period from December 31, 2020, and the period from October 16, 2020 (inception) through December 31, 2020 (collectively, the “Affected Period”), are restated in our Annual Report on Form 10-K/A Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the derivative warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and Trust accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2020. As of December 31, 2020, cash held in the operating bank account was approximately $2.3 million and Cash held in the Trust Account was approximately $373.8 million. Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash, accounts payable, and accrued expenses approximate their fair values primarily due to the short-term nature of the instruments. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been measured at fair value using a Monte Carlo simulation model. Offering Costs Associated with the Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating Class A Ordinary Shares Subject to Possible Redemption Class A Ordinary Shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A Ordinary Shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’ equity. The Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, 33,044,958 Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Net Income (Loss) Per Ordinary Share Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 15,660,417 of the Company’s Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion would be anti-dilutive under the treasury stock method. The Company’s statement of operations includes a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two-class method of income Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Derivative Warrant Liabilities The Company does not use derivative instruments to hedge its exposures to cash flow, market, or foreign currency risks. Management evaluates all of the Company’s financial instruments, including issued warrants to purchase its Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. re-assessed The Company issued 9,343,750 warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 6,316,667 Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with ASC 815-40. re-measurement Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.	Note 2 — Summary of Significant Accounting Policies Basis of presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. MRAC Merger Sub Corp. during the three and six months ended June 30, 2021 did not engage in any economic activity and is not consolidated in the accompanying unaudited and condensed financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K/A Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s unaudited condensed financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the unaudited condensed balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement Class A Ordinary Shares Subject to Possible Redemption Class A Ordinary Shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A Ordinary Shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’ equity. The Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 33,137,137 and 33,044,958 Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed balance sheets. Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) per Ordinary Share The Company’s condensed statements of operations include a presentation of net income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to the two-class The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary share price for the period and therefore the inclusion of such warrants would be anti-dilutive. The following table reflects the calculation of basic and diluted net income (loss) per share of ordinary share: For The Three For The Six Months Class A Ordinary shares subject to possible redemption Numerator: Earnings allocable to Ordinary shares subject to possible redemption Income from investments held in Trust Account $ — $ — Less: Company’s portion available to be withdrawn to pay taxes — — Net income attributable $ — $ — Denominator: Weighted average Class A ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding 37,375,000 37,375,000 Basic and diluted net income per share $ — $ — For The Three For The Six Months Non-Redeemable Numerator: Net Income (Loss) minus Net Earnings Net income (loss) $ (2,984,151 ) $ 1,384,201 Net income allocable to Class A ordinary shares subject to possible redemption — — Non-redeemable $ (2,984,151 ) $ Denominator: Weighted average Non-redeemable Basic and diluted weighted average shares outstanding, Non-redeemable 9,343,750 9,343,750 Basic and diluted net loss per share, Non-redeemable $ (0.32 ) $ 0.15 Recent Issued Accounting Standards In August 2020, the FASB issued Accounting Standard Update (the “ASU”) No. 2020-06, 470-20) 815-40): The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
Initial Public Offering	NOTE 4. INITIAL PUBLIC OFFERING On December 17, 2020, the Company consummated its Initial Public Offering of 37,375,000 Units, including 4,875,000 Over-Allotment Units at $10.00 per Unit, generating gross proceeds of approximately $373.8 million, and incurring offering costs of approximately $19.5 million, of which approximately $13.1 million was deferred underwriting commissions. Each Unit consists of one Class A ordinary share, and one-fourth of one redeemable warrant (each,	Note 3 — Initial Public Offering On December 17, 2020, the Company consummated its Initial Public Offering of 37,375,000 Units, including 4,875,000 Over-Allotment Units at $10.00 per Unit, generating gross proceeds of approximately $373.8 million, and incurring offering costs of approximately $19.9 million, of which approximately $13.1 million was deferred underwriting commissions and $0.5 million was deferred legal fees. Each Unit consists of one Class A ordinary share, and one-fourth

Related Party Transactions

Related Party Transactions	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On October 28, 2020, the Sponsor paid $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 10,062,500 Class B Ordinary Shares, par value $0.0001, (the “Founder Shares”). On November 10, 2020, the Sponsor surrendered 718,750 Founder Shares to the Company for no consideration, resulting in an aggregate of 9,343,750 Founder Shares outstanding. All shares and associated amounts have been retroactively restated to reflect the share surrender. The Sponsor agreed to forfeit up to 1,218,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriter, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On December 15, 2020, the underwriter fully exercised its over-allotment option; thus, these Founder Shares were no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (a) one year after the completion of the Business Combination and (b) upon completion of the Business Combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 6,316,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $9.5 million. Each whole Private Placement Warrant is exercisable for one whole Class A Ordinary Share at a price of $11.50 per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Business Combination. Related Party Loans On October 28, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“working capital loans”). If the Company completes a Business Combination, the Company would repay the working capital loans out of the proceeds of the Trust Account released to the Company. Otherwise, the working capital loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the working capital loans but no proceeds held in the Trust Account would be used to repay the working capital loans. Except for the foregoing, the terms of such working capital loans, if any, have not been determined and no written agreements exist with respect to such loans. The working capital loans would either be repaid upon completion of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such working capital loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of the December 31, 2020, the Company had no borrowings under the working capital loans. Administrative Support Agreement Commencing on December 14, 2020, the Company agreed to reimburse the Sponsor for out-of-pocket reasonable fees and out-of-pocket expenses incurred in	Note 4 — Related Party Transactions Founder Shares On October 28, 2020, the Sponsor paid $25,000 to cover certain expenses on behalf of the Company in exchange for the issuance of 10,062,500 Class B Ordinary Shares, par value $0.0001, (the “Founder Shares”). On November 10, 2020, the Sponsor surrendered 718,750 Founder Shares to the Company for no consideration, resulting in an aggregate of 9,343,750 Founder Shares outstanding. All shares and associated amounts have been retroactively restated to reflect the share surrender. The Sponsor agreed to forfeit up to 1,218,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriter, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. On December 15, 2020, the underwriter fully exercised its over-allotment option; thus, these Founder Shares were no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (a) one year after the completion of the Business Combination and (b) upon completion of the Business Combination, (x) if the last reported sale price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 6,316,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with the Sponsor, generating gross proceeds of approximately $9.5 million. Each whole Private Placement Warrant is exercisable for one whole Class A Ordinary Share at a price of $11.50 per share. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Business Combination. Related Party Loans On October 28, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“working capital loans”). If the Company completes a Business Combination, the Company would repay the working capital loans out of the proceeds of the Trust Account released to the Company. Otherwise, the working capital loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the working capital loans but no proceeds held in the Trust Account would be used to repay the working capital loans. Except for the foregoing, the terms of such working capital loans, if any, have not been determined and no written agreements exist with respect to such loans. The working capital loans would either be repaid upon completion of a Business Combination, without interest, or, at the lenders’ discretion, up to $1.5 million of such working capital loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of the June 30, 2021 and December 31, 2020, the Company had no borrowings under the working capital loans. Administrative Support Agreement Commencing on December 14, 2020, the Company agreed to reimburse the Sponsor for out-of-pocket out-of-pocket

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 6. COMMITMENTS & CONTINGENCIES Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon completion of the Initial Public Offering. These holders were entitled to certain demand and “piggyback” registration rights. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up Underwriting Agreement The Company granted the underwriter a 45-day option from the final prospectus The underwriter was entitled to an underwriting discount of $0.20 per unit, or approximately $7.5 million in the aggregate, paid upon the closing of the Initial Public Offering. The underwriter also reimbursed approximately $3.0 million to the Company to cover for expenses in connection with the Initial Public Offering. In addition, $0.35 per unit, or approximately $13.1 million in the aggregate will be payable to the underwriter for deferred underwriting commissions. The deferred fee will become payable to the underwriter from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the	Note 5 — Commitments and Contingencies Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any Class A Ordinary Shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans) were entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon completion of the Initial Public Offering. These holders were entitled to certain demand and “piggyback” registration rights. However, the registration and shareholder rights agreement provide that the Company will not permit any registration statement filed under the Securities Act to become effective until the termination of the applicable lock-up Underwriting Agreement The Company granted the underwriter a 45-day The underwriter was entitled to an underwriting discount of $0.20 per unit, or approximately $7.5 million in the aggregate, paid upon the closing of the Initial Public Offering. The underwriter also reimbursed approximately $3.0 million to the Company to cover for expenses in connection with the Initial Public Offering. In addition, $0.35 per unit, or approximately $13.1 million in the aggregate will be payable to the underwriter for deferred underwriting commissions and $0.01 per unit, or approximately $0.5 million in the aggregate will be payable to the attorneys for deferred legal fees. The deferred fees will become payable to the underwriter and attorneys from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19

Derivative Warrant Liabilities

Derivative Warrant Liabilities	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Warrants and Rights Note Disclosure [Abstract]
Derivative Warrant Liabilities	NOTE 7. DERIVATIVE WARRANT LIABILITIES The Company issued 9,343,750 warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 6,316,667 Private Placement Warrants. Warrants may only be exercised for a whole number of shares. The warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of the Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A Ordinary Shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A Ordinary Shares until the warrants expire or are redeemed, as specified in the warrant agreement provided that if the Class A Ordinary Shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per whole share, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to Marquee and The Raine Group or their respective affiliates, without taking into account the transfer of Founder Shares or private Placement warrants (including if such transfer is effectuated as a surrender to the Company and subsequent reissuance by to the Company) by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the completion of the Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company completes its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $18.00. • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sale price of Class A Ordinary Shares for any 20 trading days within a 30-trading day period ending The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the 30-day redemption period. If Except as set forth below, none of the Private Placement Warrants will be redeemable by the Company so long as they are held by the Sponsor or its permitted transferees. Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $10.00. • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided • if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like); and • if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holders’ ability to cashless exercise its warrants) as the outstanding warrants, as described above. The “fair market value” of the Class A ordinary shares for the above purpose shall mean the volume-weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).	Note 6 — Derivative Warrant Liabilities As of June 30, 2021 and December 31, 2020, the Company has 9,343,750 and 6,316,667 Public Warrants and Private Placement Warrants, respectively, outstanding. Warrants may only be exercised for a whole number of shares. The warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of the Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A Ordinary Shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A Ordinary Shares until the warrants expire or are redeemed, as specified in the warrant agreement provided that if the Class A Ordinary Shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A Ordinary Shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Our warrants have an exercise price of $11.50 per whole share, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A Ordinary Shares or equity-linked securities for capital raising purposes in connection with the closing of the Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company and, (i) in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to Marquee and The Raine Group or their respective affiliates, without taking into account the transfer of Founder Shares or private Placement warrants (including if such transfer is effectuated as a surrender to the Company and subsequent reissuance by to the Company) by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the completion of the Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A Ordinary Shares during the 20 trading day period starting on the trading day prior to the day on which the Company completes its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and $18.00 per share redemption trigger prices described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively. Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption; and • if, and only if, the last reported sale price of Class A Ordinary Shares for any 20 trading days within a 30-trading The Company will not redeem the warrants as described above unless a registration statement under the Securities Act covering the Class A Ordinary Shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A Ordinary Shares is available throughout the 30-day Except as set forth below, none of the Private Placement Warrants will be redeemable by the Company so long as they are held by the Sponsor or its permitted transferees. Redemption of warrants when the price per Class A Ordinary Share equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except as described herein with respect to the Private Placement Warrants): • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided • if, and only if, the Reference Value equals or exceeds $10.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like); and • if the Reference Value is less than $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like), the Private Placement Warrants must also concurrently be called for redemption on the same terms (except as described herein with respect to a holders’ ability to cashless exercise its warrants) as the outstanding warrants, as described above. The “fair market value” of the Class A Ordinary Shares for the above purpose shall mean the volume-weighted average price of Class A Ordinary Shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A Ordinary Shares per warrant (subject to adjustment). If the Company has not completed the Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Shareholders' Equity

Shareholders' Equity	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Stockholders' Equity Note [Abstract]
Stockholders' Equity	NOTE 8. SHAREHOLDERS’ EQUITY Preference Shares Class A Ordinary Shares Class B Ordinary Shares Prior to the Business Combination, only holders of the Founder Shares will have the right to vote on the appointment of directors. Holders of the Founder Shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of a Business Combination, holders of a majority of the Founder Shares may remove a member of the Board for any reason. These provisions of the amended and restated memorandum and articles of association may only be amended by a special resolution passed by not less than two-thirds of the ordinary The Founder Shares will automatically convert into Class A Ordinary Shares on the first business day following the completion of the Business Combination at a ratio such that the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of	Note 7 — Shareholders’ Equity Preference Shares Class A Ordinary Shares Class B Ordinary Shares Prior to the Business Combination, only holders of the Founder Shares will have the right to vote on the appointment of directors. Holders of the Founder Shares will not be entitled to vote on the appointment of directors during such time. In addition, prior to the completion of a Business Combination, holders of a majority of the Founder Shares may remove a member of the Board for any reason. These provisions of the amended and restated memorandum and articles of association may only be amended by a special resolution passed by not less than two-thirds of the shareholders, including any vote in connection with the Business Combination, except as required by law, holders of the Class A Ordinary Shares and Founder Shares will vote together as a single class, with each share entitling the holder to one vote. The Founder Shares will automatically convert into Class A Ordinary Shares on the first business day following the completion of the Business Combination at a ratio such that the number of Class A Ordinary Shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted

Fair Value Measurements

Fair Value Measurements	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	NOTE 9. FAIR VALUE MEASUREMENT The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy: Description Quoted Prices in Significant Other Significant Other Liabilities: Derivative warrant liabilities $ — $ — $ 27,249,130 Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels of the hierarchy in during the period from October 16, 2020 (inception) through December 31, 2020. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially and subsequently measured at fair value using a Monte Carlo simulation model at each measurement date. For the period ended December 31, 2020, the Company recognized a charge to the statement of operations resulting from an increase in the fair value of liabilities of approximately $3.8 million presented as change in fair value of derivative warrant liabilities on the accompanying statement of operations. The estimated fair value of the Private Placement Warrants and the Public Warrants, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the volatility of its Class A ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement: As of As of Volatility 22.4 % 21.7 % Stock price $ 10.45 $ 10.40 Expected life of the options to convert 5.5 5.5 Risk-free rate 0.45 % 0.43 % Dividend yield 0.0 % 0.0 % The change in the fair value of the derivative warrant liabilities for the period from October 16, 2020 (inception) through December 31, 2020 is summarized as follows: Derivative warrant liabilities at October 16, 2020 (inception) $ — Issuance of Public and Private Warrants 23,490,630 Change in fair value of derivative warrant liabilities 3,758,500 Derivative warrant liabilities at December 31, 2020 $ 27,249,130	Note 8 — Fair Value Measurements The following table presents information about the Company’s liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. June 30, 2021 Description Quoted Prices in Active Significant Other Significant Other Liabilities: Derivative warrant liabilities - Public $ 11,960,000 $ — $ — Derivative warrant liabilities - Private $ — $ 8,085,330 $ — December 31, 2020 Description Quoted Prices in Active Significant Other Significant Other Liabilities: Derivative warrant liabilities - Public $ — $ — $ 16,258,130 Derivative warrant liabilities - Private $ — $ — $ 10,991,000 Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 measurement to a Level 1 fair value measurement in January 2021, as the Public Warrants were separately listed and traded in the quarter ended March 31, 2021. The estimated fair value of the Private Warrants was transferred from a Level 3 measurement to a Level 2 fair value measurement as of April 2021, as the key inputs to the valuation model became directly or indirectly observable from the Public Warrants listed price. The change in the fair value of the derivative warrant liabilities, measured using level 3 inputs, for the three and six months ended June 30, 2021 is summarized as follows: Level 3 - Derivative warrant liabilities at December 31, 2020 $ 27,249,130 Change in fair value of derivative warrant liabilities (3,158,330 ) Transfer of Public Warrants out of level 3 (16,258,130 ) Level 3 - Derivative warrant liabilities at March 31, 2021 $ 7,832,670 Transfer of Private Warrants out of level 3 (7,832,670 ) Level 3 - Derivative warrant liabilities at June 30, 2021 $ —

Subsequent Events

Subsequent Events	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Subsequent Events [Abstract]
Subsequent Events	NOTE 10. SUBSEQUENT EVENTS On April 28, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with MRAC Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of the Company, and Enjoy Technology Inc., a Delaware corporation. Pursuant to the Merger Agreement, the parties thereto will enter into a business combination transaction. The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described herein, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.	Note 9 — Subsequent Events Management has evaluated subsequent events to determine if events or transactions occurring through the date the condensed financial statements were issued, require potential adjustment to or disclosure in the condensed financial statements and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of presentation	Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for financial information and pursuant to the rules and regulations of the SEC. As described in Note 2—Restatement of Previously Issued Financial Statements, the Company’s financial statements for the period from December 31, 2020, and the period from October 16, 2020 (inception) through December 31, 2020 (collectively, the “Affected Period”), are restated in our Annual Report on Form 10-K/A	Basis of presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. MRAC Merger Sub Corp. during the three and six months ended June 30, 2021 did not engage in any economic activity and is not consolidated in the accompanying unaudited and condensed financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three and six months ended June 30, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 10-K/A
Emerging growth company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth	Emerging growth company As an emerging growth company, the Company may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging This may make comparison of the Company’s unaudited condensed financial statement with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the derivative warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentrations of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and Trust accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. At December 31, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. As of June 30, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2020. As of December 31, 2020, cash held in the operating bank account was approximately $2.3 million and Cash held in the Trust Account was approximately $373.8 million.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.
Fair Value of Financial Instruments	Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2020, the carrying values of cash, accounts payable, and accrued expenses approximate their fair values primarily due to the short-term nature of the instruments. The fair value of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants have been measured at fair value using a Monte Carlo simulation model.	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements” approximates the carrying amounts represented in the unaudited condensed balance sheets.
Fair Value Measurements		Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the balance sheet date that are directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting fees and other costs incurred that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as non-operating
Derivative Warrant Liabilities	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge its exposures to cash flow, market, or foreign currency risks. Management evaluates all of the Company’s financial instruments, including issued warrants to purchase its Class A ordinary shares, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. re-assessed The Company issued 9,343,750 warrants to purchase Class A ordinary shares to investors in the Company’s Initial Public Offering and simultaneously issued 6,316,667 Private Placement Warrants. All of the Company’s outstanding warrants are recognized as derivative liabilities in accordance with ASC 815-40. re-measurement	Derivative Warrant Liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to re-measurement
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption Class A Ordinary Shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A Ordinary Shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’ equity. The Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, 33,044,958 Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.	Class A Ordinary Shares Subject to Possible Redemption Class A Ordinary Shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A Ordinary Shares (including Class A Ordinary Shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A Ordinary Shares are classified as shareholders’ equity. The Class A Ordinary Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at June 30, 2021 and December 31, 2020, 33,137,137 and 33,044,958 Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, respectively, outside of the shareholders’ equity section of the Company’s unaudited condensed balance sheets.
Income Taxes	Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2020. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.	Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) per Ordinary Share	Net Income (Loss) Per Ordinary Share Net income (loss) per share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the period. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 15,660,417 of the Company’s Class A Ordinary Shares in the calculation of diluted income (loss) per share, since their inclusion would be anti-dilutive under the treasury stock method. The Company’s statement of operations includes a presentation of income per share for ordinary shares subject to redemption in a manner similar to the two-class method of income	Net Income (Loss) per Ordinary Share The Company’s condensed statements of operations include a presentation of net income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to the two-class The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the Initial Public Offering and Private Placement since the exercise price of the warrants is in excess of the average ordinary share price for the period and therefore the inclusion of such warrants would be anti-dilutive. The following table reflects the calculation of basic and diluted net income (loss) per share of ordinary share: For The Three For The Six Months Class A Ordinary shares subject to possible redemption Numerator: Earnings allocable to Ordinary shares subject to possible redemption Income from investments held in Trust Account $ — $ — Less: Company’s portion available to be withdrawn to pay taxes — — Net income attributable $ — $ — Denominator: Weighted average Class A ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding 37,375,000 37,375,000 Basic and diluted net income per share $ — $ — For The Three For The Six Months Non-Redeemable Numerator: Net Income (Loss) minus Net Earnings Net income (loss) $ (2,984,151 ) $ 1,384,201 Net income allocable to Class A ordinary shares subject to possible redemption — — Non-redeemable $ (2,984,151 ) $ Denominator: Weighted average Non-redeemable Basic and diluted weighted average shares outstanding, Non-redeemable 9,343,750 9,343,750 Basic and diluted net loss per share, Non-redeemable $ (0.32 ) $ 0.15
Recent Issued Accounting Standards	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.	Recent Issued Accounting Standards In August 2020, the FASB issued Accounting Standard Update (the “ASU”) No. 2020-06, 470-20) 815-40): The Company’s management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	3 Months Ended
	Dec. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Summary of Restatement of Financial Statements	The impact of the restatement on the balance sheets, statement of operations and statement of cash flows for the Affected Period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. As of December 31, 2020 As Previously Restatement As Restated Balance Sheet Total assets $ 376,847,694 $ — $ 376,847,694 Liabilities and shareholders’ equity Total current liabilities $ 1,067,726 $ — $ 1,067,726 Deferred legal fees — — Deferred underwriting commissions 13,081,250 — 13,081,250 Derivative warrant liabilities — 27,249,130 27,249,130 Total liabilities 14,148,976 27,249,130 41,398,106 Class A ordinary shares, $0.0001 par value; shares subject to possible redemption 357,698,710 (27,249,130 ) 330,449,580 Shareholders’ equity Preference shares—$0.0001 par value — — — Class A ordinary shares—$0.0001 par value 161 272 433 Class B ordinary shares—$0.0001 par value 934 — 934 Additional paid-in-capital 5,126,604 4,704,238 9,830,842 Accumulated deficit (127,691 ) (4,704,510 ) (4,832,201 ) Total shareholders’ equity 5,000,008 — 5,000,008 Total liabilities and shareholders’ equity $ 376,847,694 $ — $ 376,847,694 Period From October 16, 2020 (Inception) As Previously Restatement As Restated Statement of Operations Loss from operations $ (127,691 ) $ — $ (127,691 ) Other (expense) income: Change in fair value of derivative warrant liabilities — (3,758,500 ) (3,758,500 ) Transaction costs—derivative warrant liabilities — (946,010 ) (946,010 ) Net gain from investments held in Trust Account — — — Total other (expense) income — (4,704,510 ) (4,704,510 ) Net loss $ (127,691 ) $ (4,704,510 ) $ (4,832,201 ) Basic and Diluted weighted-average Class A ordinary shares outstanding 37,375,000 — 37,375,000 Basic and Diluted net loss per Class A share $ — — $ — Basic and Diluted weighted-average Class B ordinary shares outstanding 8,429,688 — 8,429,688 Basic and Diluted net loss per Class B share $ (0.02 ) $ (0.55 ) $ (0.57 ) Period From October 16, 2020 (Inception) Through As Previously Restatement As Restated Statement of Cash Flows Net loss $ (127,691 ) $ (4,704,510 ) $ (4,832,201 ) Change in fair value of derivative warrant liabilities — 3,758,500 3,758,500 Transaction costs - derivative warrant liabilities — 946,010 946,010

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Summary of basic and diluted net income per shares	The following table reflects the calculation of basic and diluted net income (loss) per share of ordinary share: For The Three For The Six Months Class A Ordinary shares subject to possible redemption Numerator: Earnings allocable to Ordinary shares subject to possible redemption Income from investments held in Trust Account $ — $ — Less: Company’s portion available to be withdrawn to pay taxes — — Net income attributable $ — $ — Denominator: Weighted average Class A ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding 37,375,000 37,375,000 Basic and diluted net income per share $ — $ — For The Three For The Six Months Non-Redeemable Numerator: Net Income (Loss) minus Net Earnings Net income (loss) $ (2,984,151 ) $ 1,384,201 Net income allocable to Class A ordinary shares subject to possible redemption — — Non-redeemable $ (2,984,151 ) $ Denominator: Weighted average Non-redeemable Basic and diluted weighted average shares outstanding, Non-redeemable 9,343,750 9,343,750 Basic and diluted net loss per share, Non-redeemable $ (0.32 ) $ 0.15

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis	The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of December 31, 2020 by level within the fair value hierarchy: Description Quoted Prices in Significant Other Significant Other Liabilities: Derivative warrant liabilities $ — $ — $ 27,249,130	The following table presents information about the Company’s liabilities measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. June 30, 2021 Description Quoted Prices in Active Significant Other Significant Other Liabilities: Derivative warrant liabilities - Public $ 11,960,000 $ — $ — Derivative warrant liabilities - Private $ — $ 8,085,330 $ — December 31, 2020 Description Quoted Prices in Active Significant Other Significant Other Liabilities: Derivative warrant liabilities - Public $ — $ — $ 16,258,130 Derivative warrant liabilities - Private $ — $ — $ 10,991,000
Summary of Change in the Fair Value of the Derivative Warrant Liabilities	The change in the fair value of the derivative warrant liabilities for the period from October 16, 2020 (inception) through December 31, 2020 is summarized as follows: Derivative warrant liabilities at October 16, 2020 (inception) $ — Issuance of Public and Private Warrants 23,490,630 Change in fair value of derivative warrant liabilities 3,758,500 Derivative warrant liabilities at December 31, 2020 $ 27,249,130	The change in the fair value of the derivative warrant liabilities, measured using level 3 inputs, for the three and six months ended June 30, 2021 is summarized as follows: Level 3 - Derivative warrant liabilities at December 31, 2020 $ 27,249,130 Change in fair value of derivative warrant liabilities (3,158,330 ) Transfer of Public Warrants out of level 3 (16,258,130 ) Level 3 - Derivative warrant liabilities at March 31, 2021 $ 7,832,670 Transfer of Private Warrants out of level 3 (7,832,670 ) Level 3 - Derivative warrant liabilities at June 30, 2021 $ —
Summary of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs	The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement: As of As of Volatility 22.4 % 21.7 % Stock price $ 10.45 $ 10.40 Expected life of the options to convert 5.5 5.5 Risk-free rate 0.45 % 0.43 % Dividend yield 0.0 % 0.0 %

Description of Organization a_2

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)	Apr. 28, 2021	Dec. 17, 2020	Oct. 28, 2020	Dec. 31, 2020	Jun. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Shares issued price per share		$ 10
Proceeds from issuance of IPO				$ 373,750,000
Offering costs		$ 19,500,000
Deferred underwriting commissions		13,100,000		13,081,250	$ 13,081,250
Proceeds from issuance of warrants		$ 373,800,000
Restricted investments term		185 days
Value per share		$ 10
Net tangible assets for consummation of business combination		$ 5,000,001
Percentage of redeeming shares of public shares without the company's prior written consent		15.00%
Dissolution expense		$ 100,000
Cash				2,266,049	$ 877,620
Proceeds from lines of credit				127,850
Stock issued during period value issued for services				25,000
Net working capital				$ 2,000,000
Business Acquisitions [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business Acquisition, Share Price	$ 10
Business Acquisitions [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business acquisitions purchase price allocation	$ 1,028,738,000
Business combination step acquisition percentage	125.00%
Minimum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of fair market value of business combination		80.00%
Maximum aggregate business acquisitions amount	$ 15,000,000
Minimum [Member] | Business Acquisitions [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Business acquisition percentage of voting interests acquired		50.00%
Maximum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Maximum aggregate business acquisitions amount	$ 60,000,000
Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of redeeming shares of public shares without the company's prior written consent		100.00%
Business combination period		24 months
PIPE Investors [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period shares	8,000,000
Stock issued during period value issued for services	$ 80,000,000
Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Value per share		$ 11.50		$ 9.20	$ 9.20
Ordinary shares par value	$ 0.0001			$ 0.0001	$ 0.0001
Stock conversion basis	one-for-one
Ordinary shares issued				4,330,042	4,237,863
Common Class B [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Ordinary shares par value	$ 0.0001			$ 0.0001	$ 0.0001
Stock conversion basis	one-for-one
Ordinary shares issued				9,343,750	9,343,750
Founder Share Amount [Member] | Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period value issued for services					$ 25,000
Founder Shares [Member] | Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period shares			10,062,500
Proceeds from lines of credit					$ 128,000
Founder Shares [Member] | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock conversion basis				one to one	one to one
Founder Shares [Member] | Common Class B [Member] | Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Ordinary shares par value			$ 0.0001
Ordinary Shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Value per share	$ 15
Ordinary shares issued	1,121,250
Number of trading days for determining the share price	20 days
Number Of Consecutive Trading Days For Determining The Share Price	30 days
Ordinary Shares | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period shares				37,375,000
Ordinary Shares | Common Class B [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during period value issued for services				$ 934
Operating Bank Account [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash				$ 2,300,000	$ 878,000
Working deficit					$ 3,800,000
Private Placement Warrants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance of warrants		$ 9,500,000
Private Placement Warrants [Member] | Sponsor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Class of warrants and rights issued during the period		6,316,667
Class of warrants and rights issued price per warrant		$ 1.50
IPO [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Offering costs		$ 19,900,000
Deferred underwriting commissions		$ 13,100,000
Value per share		$ 10
IPO [Member] | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period shares		37,375,000
Shares issued price per share		$ 10
Proceeds from issuance of IPO		$ 373,800,000
Stock conversion basis		Each Unit consists of one Class A ordinary share, and one-fourth of one redeemable warrant (each, a “Public warrant”).
Over-Allotment Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period shares				4,875,000	4,875,000
Over-Allotment Option [Member] | Common Class A [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period shares		4,875,000

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements - Summary of Restatement of Financial Statements (Detail) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2021	Dec. 17, 2020	Oct. 15, 2020
Statement of Financial Position [Abstract]
Total assets	$ 375,264,188		$ 376,847,694	$ 375,264,188
Liabilities, Current [Abstract]
Total current liabilities	5,303,819		1,067,726	5,303,819
Deferred legal fees	500,000			500,000	$ 500,000
Deferred underwriting commissions	13,081,250		13,081,250	13,081,250	$ 13,100,000
Derivative warrant liabilities	20,045,330		27,249,130	20,045,330
Total liabilities	38,892,808		41,398,106	38,892,808
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption	331,371,370		330,449,580	331,371,370
Shareholders' Equity
Preference shares—$0.0001 par value	0		0	0
Additional paid-in capital	8,446,652		9,830,842	8,446,652
Accumulated deficit	(3,448,000)		(4,832,201)	(3,448,000)
Total shareholders' equity	5,000,010	$ 5,000,008	5,000,008	5,000,010		$ 0
Total liabilities and shareholders' equity	375,264,188		376,847,694	375,264,188
Statement of Operations
Loss from operations	(2,357,741)		(127,691)	(5,819,599)
Other (expense) income:
Change in fair value of derivative warrant liabilities	(626,410)		(3,758,500)	7,203,800
Transaction costs—derivative warrant liabilities			(946,010)
Total other (expense) income			(4,704,510)
Net loss	(2,984,151)	$ 4,368,352	(4,832,201)	1,384,201
Statement of Cash Flows
Net loss			(4,832,201)	1,384,201
Change in fair value of derivative warrant liabilities	626,410		3,758,500	(7,203,800)
Transaction costs - derivative warrant liabilities			946,010
Common Class A [Member]
Shareholders' Equity
Common Stock	$ 424		$ 433	$ 424
Other (expense) income:
Weighted average ordinary shares outstanding, basic and diluted	37,375,000		37,375,000	37,375,000
Basic and diluted net income per ordinary share	$ 0		$ 0	$ 0
Common Class B [Member]
Shareholders' Equity
Common Stock	$ 934		$ 934	$ 934
Other (expense) income:
Weighted average ordinary shares outstanding, basic and diluted	9,343,750		8,429,688	9,343,750
Basic and diluted net income per ordinary share	$ (0.32)		$ (0.57)	$ 0.15
As Previously Reported [Member]
Statement of Financial Position [Abstract]
Total assets			$ 376,847,694
Liabilities, Current [Abstract]
Total current liabilities			1,067,726
Deferred legal fees			0
Deferred underwriting commissions			13,081,250
Total liabilities			14,148,976
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption			357,698,710
Shareholders' Equity
Preference shares—$0.0001 par value			0
Additional paid-in capital			5,126,604
Accumulated deficit			(127,691)
Total shareholders' equity			5,000,008
Total liabilities and shareholders' equity			376,847,694
Statement of Operations
Loss from operations			(127,691)
Other (expense) income:
Net gain from investments held in Trust Account			0
Net loss			(127,691)
Statement of Cash Flows
Net loss			(127,691)
As Previously Reported [Member] | Common Class A [Member]
Shareholders' Equity
Common Stock			$ 161
Other (expense) income:
Weighted average ordinary shares outstanding, basic and diluted			37,375,000
Basic and diluted net income per ordinary share			$ 0
As Previously Reported [Member] | Common Class B [Member]
Shareholders' Equity
Common Stock			$ 934
Other (expense) income:
Weighted average ordinary shares outstanding, basic and diluted			8,429,688
Basic and diluted net income per ordinary share			$ (0.02)
Restatement Adjustment [Member]
Liabilities, Current [Abstract]
Derivative warrant liabilities			$ 27,249,130
Total liabilities			27,249,130
Class A ordinary shares, $0.0001 par value; shares subject to possible redemption			(27,249,130)
Shareholders' Equity
Additional paid-in capital			4,704,238
Accumulated deficit			(4,704,510)
Other (expense) income:
Change in fair value of derivative warrant liabilities			(3,758,500)
Transaction costs—derivative warrant liabilities			(946,010)
Total other (expense) income			(4,704,510)
Net loss			(4,704,510)
Statement of Cash Flows
Net loss			(4,704,510)
Change in fair value of derivative warrant liabilities			3,758,500
Transaction costs - derivative warrant liabilities			946,010
Restatement Adjustment [Member] | Common Class A [Member]
Shareholders' Equity
Common Stock			$ 272
Restatement Adjustment [Member] | Common Class B [Member]
Other (expense) income:
Basic and diluted net income per ordinary share			$ (0.55)

Restatement of Previously Iss_4

Restatement of Previously Issued Financial Statements - Summary of Restatement of Financial Statements (Parenthetical) (Detail) - $ / shares	Jun. 30, 2021	Apr. 28, 2021	Dec. 31, 2020
Accounting Changes [Line Items]
Preference shares par value	$ 0.0001		$ 0.0001
As Previously Reported [Member]
Accounting Changes [Line Items]
Preference shares par value			0.0001
Restatement Adjustment [Member]
Accounting Changes [Line Items]
Preference shares par value			0.0001
Common Class A [Member]
Accounting Changes [Line Items]
Class A ordinary shares par value	0.0001		0.0001
Ordinary shares par value	0.0001	$ 0.0001	0.0001
Common Class A [Member] | As Previously Reported [Member]
Accounting Changes [Line Items]
Class A ordinary shares par value			0.0001
Ordinary shares par value			0.0001
Common Class A [Member] | Restatement Adjustment [Member]
Accounting Changes [Line Items]
Class A ordinary shares par value			0.0001
Ordinary shares par value			0.0001
Common Class B [Member]
Accounting Changes [Line Items]
Ordinary shares par value	$ 0.0001	$ 0.0001	0.0001
Common Class B [Member] | As Previously Reported [Member]
Accounting Changes [Line Items]
Ordinary shares par value			0.0001
Common Class B [Member] | Restatement Adjustment [Member]
Accounting Changes [Line Items]
Ordinary shares par value			$ 0.0001

Restatement of Previously Iss_5

Restatement of Previously Issued Financial Statements - Additional Information (Detail) $ in Millions	Dec. 23, 2020USD ($)
Restatement Adjustment [Member]
Accounting Changes [Line Items]
Reclassification from temporary equity to derivative warrant liabilities	$ 23.5

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
Federal depository insurance coverage	$ 250,000	$ 250,000		$ 250,000
Cash equivalents	0		$ 0	0
Cash at bank	877,620		2,266,049	877,620
Cash held in trust account			373,800,000
Transaction costs—derivative warrant liabilities			946,010
Offering costs	196,307	266,102	19,477,581
Profit loss			(4,832,201)	1,384,201
Net income loss	$ (2,984,151)	$ 4,368,352	(4,832,201)	1,384,201
IPO [Member]
Reimbursement received			$ 3,000,000	$ 3,000,000
Warrant [Member]
Antidilutive securities excluded from computation of earnings per share amount			15,660,417
Common Class A [Member]
Ordinary shares subject to possible redemption	33,137,137		33,044,958	33,137,137
Interest income from investment in trust account net of taxes			$ 0
Net income loss attributable to redeemable non controlling interest			$ 0
Common Class A [Member] | IPO [Member]
Number of warrants or rights outstanding			9,343,750
Private Placement Warrants [Member]
Number of warrants or rights outstanding			6,316,667

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of basic and diluted net income per shares (Detail) - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Jun. 30, 2021
Numerator: Net Income (Loss) minus Net Earnings
Net income (loss)	$ (2,984,151)	$ 4,368,352	$ (4,832,201)	$ 1,384,201
Class A Redeemable Common Stock [Member]
Numerator: Earnings allocable to Ordinary shares subject to possible redemption
Income from investments held in Trust Account	0			0
Less: Company's portion available to be withdrawn to pay taxes	0			0
Net income attributable	$ 0			$ 0
Basic and diluted weighted average shares outstanding	37,375,000			37,375,000
Basic and diluted net income per share	$ 0			$ 0
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares	37,375,000			37,375,000
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ 0			$ 0
Class A Nonredeemable Common Stock [Member]
Numerator: Earnings allocable to Ordinary shares subject to possible redemption
Basic and diluted weighted average shares outstanding	9,343,750			9,343,750
Basic and diluted net income per share	$ (0.32)			$ 0.15
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares	9,343,750			9,343,750
Basic and diluted net loss per share, Non-redeemable ordinary shares	$ (0.32)			$ 0.15
Numerator: Net Income (Loss) minus Net Earnings
Net income (loss)	$ (2,984,151)			$ 1,384,201
Net income allocable to Class A ordinary shares subject to possible redemption	0			0
Non-redeemable net income (loss)	$ (2,984,151)			$ 1,384,201

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Detail) - USD ($)	Apr. 28, 2021	Dec. 17, 2020	Dec. 31, 2020	Jun. 30, 2021
Proceeds from initial public offer			$ 373,750,000
Offering costs		$ 19,500,000
Deferred underwriting commissions		$ 13,100,000	$ 13,081,250	$ 13,081,250
Share price per share		$ 10
Deferred legal fees		$ 500,000		$ 500,000
IPO [Member]
Offering costs		19,900,000
Deferred underwriting commissions		$ 13,100,000
Share price per share		$ 10
Over-Allotment Option [Member]
Stock issued during the period shares			4,875,000	4,875,000
Common Class A [Member]
Share price per share		$ 11.50	$ 9.20	$ 9.20
Stock conversion basis	one-for-one
Shares issuable per warrant			0.361	0.361
Common Class A [Member] | IPO [Member]
Stock issued during the period shares		37,375,000
Sale of stock issue price per share		$ 10
Proceeds from initial public offer		$ 373,800,000
Stock conversion basis		Each Unit consists of one Class A ordinary share, and one-fourth of one redeemable warrant (each, a “Public warrant”).
Common Class A [Member] | Over-Allotment Option [Member]
Stock issued during the period shares		4,875,000
Public Warrant [Member] | Common Class A [Member]
Shares issuable per warrant		1
Exercise price of warrant		$ 11.50

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($)	Nov. 10, 2020	Oct. 28, 2020	Jun. 30, 2021	Dec. 31, 2020	Jun. 30, 2021	Apr. 28, 2021	Dec. 17, 2020	Dec. 15, 2020
Related Party Transaction [Line Items]
Share price per share							$ 10
Proceeds from private placement warrants				$ 9,475,000
Working Capital Loans [Member]
Related Party Transaction [Line Items]
Borrowings			$ 0	$ 0	$ 0
Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Number of days after the Business Combination determining Private Placement Warrants lock in period				30 days
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Over-allotment option exercised	fully
IPO [Member]
Related Party Transaction [Line Items]
Share price per share							10
Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares outstanding	9,343,750
Founder shares agreed to be forfeited	9,343,750
Founder shares subject to forfeiture	9,343,750
Number of years after the Business Combination determining founder shares lock in period				1 year	1 year
Founder Shares [Member] | IPO [Member]
Related Party Transaction [Line Items]
Percentage of issued and outstanding shares owned by Founder Shares	20.00%
Warrant [Member]
Related Party Transaction [Line Items]
Private Placement Warrant exercise price			$ 11.50	$ 11.50	$ 11.50
Warrant [Member] | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Working capital loans convertible amount			$ 1,500,000	$ 1,500,000	$ 1,500,000
Working capital loans conversion price			$ 1.50	$ 1.50	$ 1.50
Class B [Member]
Related Party Transaction [Line Items]
Ordinary shares par value			0.0001	0.0001	0.0001	$ 0.0001
Class A [Member]
Related Party Transaction [Line Items]
Ordinary shares par value			0.0001	0.0001	0.0001	$ 0.0001
Share price per share			9.20	9.20	9.20		$ 11.50
Class A [Member] | Share Price Equals Or Exceeds 12 USD [Member]
Related Party Transaction [Line Items]
Share price per share			$ 12	$ 12	$ 12
Class A [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Number of consecutive trading days after the Business Combination determining founder shares lock in period				20 days	20 days
Number of trading days after the Business Combination determining founder shares lock in period				30 days	30 days
Threshold days after the Business Combination determining founder shares lock in period				150 days	150 days
Sponsor [Member] | Office Space And Administrative Support Services [Member]
Related Party Transaction [Line Items]
Related party expense			$ 0		$ 0
Sponsor [Member] | Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Private placement warrants shares issued				6,316,667	6,316,667
Private placement warrants shares issued price per share			$ 1.50	$ 1.50	$ 1.50
Proceeds from private placement warrants				$ 9,500,000	$ 9,500,000
Sponsor [Member] | IPO [Member] | Commercial Paper [Member]
Related Party Transaction [Line Items]
Promissory note, Face amount		$ 300,000
Promissory note, Interest rate		0.00%
Borrowings							$ 128,000
Sponsor [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Founder shares surrendered shares	718,750
Founder Shares surrendered shares, Value	$ 0
Sponsor [Member] | Founder Shares [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Founder shares outstanding	1,218,750
Founder shares agreed to be forfeited	1,218,750
Founder shares subject to forfeiture	1,218,750
Sponsor [Member] | Class B [Member] | Founder Shares [Member]
Related Party Transaction [Line Items]
Proceeds from stock issuance		$ 25,000
Issuance of Ordinary shares		10,062,500
Ordinary shares par value		$ 0.0001
Underwriters [Member] | Founder Shares [Member] | Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Founder shares outstanding	1,218,750							0
Founder shares agreed to be forfeited	1,218,750							0
Founder shares subject to forfeiture	1,218,750							0

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021	Dec. 17, 2020
Deferred underwriting commissions payable per unit	$ 0.35	$ 0.35
Deferred underwriting commissions	$ 13,081,250	$ 13,081,250	$ 13,100,000
Per unit		$ 0.01
Deferred legal fees		$ 500,000	500,000
Over-Allotment Option [Member]
Overallotment Option Vesting Period	45 days	45 days
Stock issued during the period shares	4,875,000	4,875,000
IPO [Member]
Underwriting discount paid per unit	$ 0.20	$ 0.20
Underwriting discount paid	$ 7,500,000	$ 7,500,000
Reimbursement received	$ 3,000,000	$ 3,000,000
Deferred underwriting commissions			$ 13,100,000

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Detail) - $ / shares	3 Months Ended	6 Months Ended
	Dec. 31, 2020	Jun. 30, 2021	Dec. 17, 2020
Warrants exercisable term from the date of completion of business combination	30 days	30 days
Warrants exercisable term from the closing of IPO	12 months	12 months
Minimum lock in period for SEC registration from date of business combination	20 days	20 days
Minimum lock In period to become effective after the closing of the initial Business Combination	60 days	60 days
Effective day for registration statement issuable upon exercise of the warrants	60 days	60 days
Warrants expiration term	5 years	5 years
Share price			$ 10
Percentage of capital raised for business combination to total equity Proceeds	60.00%	60.00%
Class of warrants, redemption price per unit	$ 10	$ 10
Share Price Equals or Exceeds $10 [Member]
Class of warrants, redemption price per unit	18	18
Share Price More Than or Equals To $18 [Member]
Share price	$ 18	$ 18
Number of consecutive trading days for determining share price	20 days	20 days
Class of warrants, exercise price adjustment percentage	180.00%	180.00%
Class of warrants, redemption notice period	30 days	30 days
Number of consecutive trading days for determining share price	20 days	20 days
Class of warrants, redemption price per unit	$ 0.01	$ 0.01
Number of trading days for determining share price	30 days	30 days
Share Price Less Than or Equals To $9.2 [Member]
Class of warrants, exercise price adjustment percentage	115.00%	115.00%
Share Price Less Than or Equals To $18 [Member]
Share price	$ 10	$ 10
Class of warrants, exercise price adjustment percentage	100.00%	100.00%
Class of warrants, redemption notice period	30 days	30 days
Class of warrants, redemption price per unit	$ 0.10	$ 0.10
Public Warrants [Member]
Warrants outstandings	9,343,750	9,343,750
Private Warrant [Member]
Warrants outstandings	6,316,667
Warrant [Member]
Warrants exercise price	$ 11.50	$ 11.50
Common Class A [Member]
Share price	$ 9.20	$ 9.20	$ 11.50
Securities called by each warrant	0.361	0.361
Number of days determining fair market value of the ClassA ordinary shares	10 days	10 days
Common Class A [Member] | Share Price Below $9.20 [Member]
Share price	$ 9.20	$ 9.20

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Detail) - USD ($)	Apr. 28, 2021	Dec. 17, 2020	Nov. 10, 2020	Oct. 28, 2020	Dec. 31, 2020	Jun. 30, 2021	Mar. 31, 2021	Dec. 15, 2020	Oct. 15, 2020
Preference shares authorized					5,000,000	5,000,000
Preference shares par value					$ 0.0001	$ 0.0001
Preference shares issued					0	0
Preference shares outstanding					0	0
Over-Allotment Option [Member]
Stock issued during the period shares					4,875,000	4,875,000
Founder Shares [Member]
Ordinary shares authorized					50,000,000	50,000,000
Founder shares outstanding			9,343,750
Founder Shares [Member] | Underwriters [Member] | Over-Allotment Option [Member]
Founder shares outstanding			1,218,750					0
Founder Shares [Member] | Sponsor [Member]
Stock issued during the period shares				10,062,500
Founder shares surrendered shares			718,750
Founder Shares surrendered shares, Value			$ 0
Founder Shares [Member] | Sponsor [Member] | Over-Allotment Option [Member]
Founder shares outstanding			1,218,750
Common Stock [Member]
Ordinary shares issued	1,121,250
Percentage of issued and outstanding ordinary shares owned by initial shareholders			20.00%
Common Class A [Member]
Ordinary shares authorized					500,000,000	500,000,000
Ordinary shares par value	$ 0.0001				$ 0.0001	$ 0.0001
Ordinary shares issued					4,330,042	4,237,863
Ordinary shares outstanding					4,330,042	4,237,863
Ordinary shares subject to possible redemption					33,044,958	33,137,137
Conversion basis	one-for-one
Common Class A [Member] | Over-Allotment Option [Member]
Stock issued during the period shares		4,875,000
Common Class A [Member] | Founder Shares [Member]
Voting rights					one	one
Percentage of conversion					20.00%	20.00%
Conversion basis					one to one	one to one
Common Class A [Member] | Common Stock [Member]
Stock issued during the period shares					37,375,000
Founder shares outstanding					4,330,042	4,237,863	3,919,817		0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Public Warrant [Member] | Level 1 [Member]
Liabilities:
Derivative warrant liabilities	$ 11,960,000	$ 0
Public Warrant [Member] | Level 2 [Member]
Liabilities:
Derivative warrant liabilities	0	0
Public Warrant [Member] | Level 3 [Member]
Liabilities:
Derivative warrant liabilities	0	16,258,130
Private Warrant [Member] | Level 1 [Member]
Liabilities:
Derivative warrant liabilities	0	0
Private Warrant [Member] | Level 2 [Member]
Liabilities:
Derivative warrant liabilities	8,085,330	0
Private Warrant [Member] | Level 3 [Member]
Liabilities:
Derivative warrant liabilities	$ 0	10,991,000
Public and Private Warrants [Member] | Level 1 [Member]
Liabilities:
Derivative warrant liabilities		0
Public and Private Warrants [Member] | Level 2 [Member]
Liabilities:
Derivative warrant liabilities		0
Public and Private Warrants [Member] | Level 3 [Member]
Liabilities:
Derivative warrant liabilities		$ 27,249,130

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail)	3 Months Ended		6 Months Ended
	Jun. 30, 2021USD ($)	Dec. 31, 2020USD ($)	Jun. 30, 2021USD ($)
Change in fair value of derivative warrant liabilities	$ 626,410	$ 3,758,500	$ (7,203,800)
Expected Dividend Rate [Member]
Measurement Input		0

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Change in the Fair Value of the Derivative Warrant Liabilities (Detail) - Level 3 [Member] - USD ($)	3 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative warrant liabilities	$ 7,832,670	$ 27,249,130	$ 0
Change in fair value of derivative warrant liabilities		(3,158,330)	3,758,500
Derivative warrant liabilities	0	7,832,670	27,249,130
Public Warrant [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Transfer of Public Warrants out of level 3	$ (7,832,670)	$ (16,258,130)
Public and Private Warrants [Member]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Issuance of Public and Private Warrants			$ 23,490,630

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs (Detail)	Dec. 31, 2020yr	Dec. 17, 2020yr
Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	0
Level 3 [Member] | Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	21.7	22.4
Level 3 [Member] | Stock price [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	10.40	10.45
Level 3 [Member] | Expected life of the options to convert [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	5.5	5.5
Level 3 [Member] | Risk Free Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	0.43	0.45
Level 3 [Member] | Dividend Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	0	0